Will we still be an EU notified body after 2019, when the UK is scheduled to leave the EU? This was one of the questions posed by BSI's head of medical devices Suzanne Halliday during Parliament's ongoing select health committee inquiry into the effects of Brexit. The focus was the impact on patients, and the supply and regulation of health-care products in the UK, post-EU. But Halliday was in fact one of the three panel members who were expected to be supplying the solutions.
In matters of Brexit, the questions still far outweigh the answers, and will continue to do so until the UK's trade-deal situation with EU is resolved. The cards are not...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?